Patients with cancer of the oral cavity usually present with advanced stage disease. Treatment is more disfiguring and debilitating, more expensive, and less successful for these patients compared to those with earlier stage disease. Early detection of neoplastic changes in the oral cavity may be our best method to improve patient quality of life and survival rates. Unfortunately, there is no satisfactory mechanism at present to adequately screen and detect premalignant changes and early lesions in the oral cavity. Optical spectroscopy can detect changes in tissue architecture and biochemical composition by scanning the tissue surface with a small, flexible, fiber optic probe. This has been used to discriminate between normal and malignant tissues in various sites, including the cervix and colon. Preliminary data suggests that optical spectroscopy may be useful for detecting dysplastic and neoplastic oral cavity mucosa. The objective of this developmental project is to develop a new, noninvasive method of diagnosing dysplasia and neoplasia in oral cavity mucosa using fluorescence and reflectance spectroscopy. We have established a team of clinicians, scientists and engineers to accomplish this objective through the following specific aims: 1) To measure fluorescence and reflectance spectra of normal and neoplastic oral mucosa in normal volunteers and oral cancer patients; 2) To compare spectroscopic data to clinical diagnostic criteria and standard histologic parameters, to develop and evaluate the accuracy of diagnostic algorithms for automated recognition of oral cavity neoplasia; and 3) To investigate the mechanisms of fluorescence and reflectance changes during malignant progression in oral neoplasia by correlating the morphologic and molecular tissue composition with spectroscopic findings. Using a small, fiberoptic probe, we will obtain fluorescent and reflectant spectroscopic readings from 100 normal volunteers and 100 patients with oral cavity lesions. The patient readings will be correlated with clinical and histologic parameters. Ultimately, our goal is to develop a method to provide diagnostic information in near real time that is both sensitive and specific. This non-invasive system could be employed in dental offices and cancer prevention clinics to improve the detection and diagnosis of early oral cancer.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Specialized Center (P50)
Project #
5P50DE011906-02S2
Application #
2836076
Study Section
Project Start
Project End
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Chun, Kyung-Hee; Benbrook, Doris M; Berlin, K Darrell et al. (2003) The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway. Cancer Res 63:3826-32
Higuchi, Eisaku; Chandraratna, Roshantha A S; Hong, Waun K et al. (2003) Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype. Oncogene 22:4627-35
Wang, Heng; Hicks, John; Khanbolooki, Parham et al. (2003) Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene. Am J Pathol 163:453-64
Gonzalez, Hernan E; Gujrati, Manu; Frederick, Mitchell et al. (2003) Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129:754-9
Jayakumar, Arumugam; Kang, Ya'an; Frederick, Mitchell J et al. (2003) Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis. Arch Biochem Biophys 409:367-74
Liu, Yanna; Li, Jun Z; Yuan, Xiao H et al. (2002) An AP-1 binding site mutation in HPV-16 LCR enhances E6/E7 promoter activity in human oral epithelial cells. Virus Genes 24:29-37
Yan, Chunhong; Wang, Heng; Boyd, Douglas D (2002) ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter. J Biol Chem 277:10804-12
El-Naggar, Adel K; Kim, Hyung W; Clayman, Gary L et al. (2002) Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification. Oncogene 21:8206-19
Shin, M; Yan, C; Boyd, D (2002) An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression. Biochim Biophys Acta 1589:311-6
Hayashi, K; Yokozaki, H; Naka, K et al. (2001) Overexpression of retinoic acid receptor beta induces growth arrest and apoptosis in oral cancer cell lines. Jpn J Cancer Res 92:42-50

Showing the most recent 10 out of 57 publications